Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Minocycline | 3 | 2020 | 61 | 1.320 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2020 | 131 | 1.280 |
Why?
|
| Lysosomes | 2 | 2020 | 136 | 1.180 |
Why?
|
| Iron | 2 | 2020 | 197 | 1.080 |
Why?
|
| Acetaminophen | 3 | 2020 | 111 | 0.960 |
Why?
|
| Iron Chelating Agents | 2 | 2022 | 31 | 0.750 |
Why?
|
| Mitochondria | 3 | 2022 | 643 | 0.740 |
Why?
|
| Deferoxamine | 1 | 2016 | 45 | 0.540 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2020 | 45 | 0.340 |
Why?
|
| Hepatocytes | 2 | 2020 | 205 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 2791 | 0.260 |
Why?
|
| Cell Survival | 2 | 2020 | 901 | 0.250 |
Why?
|
| Cells, Cultured | 3 | 2022 | 2673 | 0.250 |
Why?
|
| Fluorescent Dyes | 1 | 2022 | 191 | 0.190 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2020 | 21 | 0.180 |
Why?
|
| Drug Overdose | 1 | 2020 | 67 | 0.170 |
Why?
|
| Mitochondria, Liver | 1 | 2020 | 148 | 0.160 |
Why?
|
| Ruthenium Compounds | 1 | 2016 | 5 | 0.140 |
Why?
|
| Animals | 6 | 2022 | 20881 | 0.140 |
Why?
|
| Starch | 1 | 2016 | 18 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 137 | 0.130 |
Why?
|
| Mice | 4 | 2022 | 8474 | 0.130 |
Why?
|
| Tetracycline | 1 | 2014 | 29 | 0.120 |
Why?
|
| Multiple Organ Failure | 1 | 2014 | 36 | 0.120 |
Why?
|
| Shock, Hemorrhagic | 1 | 2014 | 33 | 0.120 |
Why?
|
| Doxycycline | 1 | 2014 | 49 | 0.120 |
Why?
|
| Protective Agents | 1 | 2014 | 36 | 0.120 |
Why?
|
| Fluid Therapy | 1 | 2014 | 59 | 0.120 |
Why?
|
| Resuscitation | 1 | 2014 | 77 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 499 | 0.110 |
Why?
|
| Liver | 2 | 2020 | 1118 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 1026 | 0.110 |
Why?
|
| Cyclosporine | 1 | 2013 | 121 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2016 | 718 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 318 | 0.090 |
Why?
|
| Kidney | 1 | 2014 | 945 | 0.090 |
Why?
|
| Male | 4 | 2020 | 37321 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 807 | 0.080 |
Why?
|
| Alanine Transaminase | 2 | 2020 | 137 | 0.070 |
Why?
|
| Oxyquinoline | 1 | 2022 | 6 | 0.050 |
Why?
|
| Rhodamine 123 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2022 | 27 | 0.050 |
Why?
|
| Fluorescence | 1 | 2022 | 104 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 113 | 0.050 |
Why?
|
| Benzodioxoles | 1 | 2020 | 30 | 0.040 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2020 | 27 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 87 | 0.040 |
Why?
|
| Benzamides | 1 | 2020 | 156 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 929 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 791 | 0.040 |
Why?
|
| Apoptosis | 2 | 2014 | 1641 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2014 | 39 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 243 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 233 | 0.030 |
Why?
|
| Necrosis | 1 | 2014 | 239 | 0.030 |
Why?
|
| Humans | 1 | 2020 | 68618 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 411 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 705 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 601 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2013 | 586 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1593 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2550 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 4655 | 0.020 |
Why?
|